Mario Gabelli

Mario Gabelli

Last Update: 2014-09-22

Number of Stocks: 873
Number of New Stocks: 65

Total Value: $19,117 Mil
Q/Q Turnover: 4%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

Mario Gabelli' s Profile & Performance

Profile

He is the founder, chairman, and CEO of Gabelli Asset Management Company Investors (GAMCO Investors) a $30 billion dollar global investment firm headquartered in Rye, New York. Forbes magazine's 2006 Forbes 400 rankings listed him as #346 on the list of wealthiest Americans and estimated his net worth at $1.0 billion.

Web Page:http://www.gabelli.com/

Total Holding History

Performance of Asset Fund Class AAA

YearReturn (%)S&P500 (%)Excess Gain (%)
201332.3731.550.8
20121615.40.6
2011-0.432.08-2.5
3-Year Cumulative52.9 (15.2%/year)55 (15.7%/year)-2.1 (-0.5%/year)
201023.0715.068.0
200930.5426.464.1
5-Year Cumulative145.6 (19.7%/year)125.5 (17.7%/year)20.1 (2%/year)
2008-37.2-37-0.2
200711.845.616.2
200621.8415.796.1
20054.424.91-0.5
200416.5124.5
10-Year Cumulative155.7 (9.8%/year)104.1 (7.4%/year)51.6 (2.4%/year)
200330.5728.71.9
2002-14.27-22.17.8
20010.16-11.912.1
2000-2.37-9.16.7
199928.49217.5
15-Year Cumulative259.6 (8.9%/year)98.3 (4.7%/year)161.3 (4.2%/year)
199815.9328.6-12.7
199738.0733.44.7
199613.3623-9.6
199524.9437.6-12.7
1994-0.151.3-1.4
20-Year Cumulative714.1 (11.1%/year)483.2 (9.2%/year)230.9 (1.9%/year)
199321.8410.111.7
199214.897.67.3
199118.1430.5-12.4
1990-5.8-3.1-2.7
198927.2231.7-4.5
25-Year Cumulative1513.4 (11.8%/year)1050.7 (10.3%/year)462.7 (1.5%/year)
198831.1116.614.5
198716.25.111.1

Top Ranked Articles

Mario Gabelli: Discussion on Long-Term View, Coffee and Content Business
Mario Gabelli was recently interviewed in CNBC, and he gave some of his ideas for investment, especially the long-term prospective should be used by investors. Read more...
Greenwald Investment Series: Valuing Assets, Part One
"Most look at earnings and earnings potential. Well I can't get into that game" — Walter Schloss Read more...
Value Idea: Cash America International (CSH) — Where Cash Is King
General: Read more...
Mario Gabelli's Latest Stock Picks
Mario Gabelli revealed some of his favorite stock picks for 2012 during the Barron's Roundtable. Read more...
Interview with Famous Author Joseph Calandro, Jr.
Can you tell us a little bit about your background? I started in the financial services industry while I was still in college, and have been in it ever since. After Hurricane Andrew in 1992 I started studying derivatives and liked it so I began trading. I was taught to trade by a student of the one of the traders profiled in the popular book Market Wizards so I knew what I was doing; nevertheless, I got taken out 5 years later during the Asian Contagion. That experience led me to Graham & Dodd, and to risk management. I am now consulting on M&A using Graham & Dodd valuation and, incredible as it may seem, as far as I know I am the first person to do so. Read more...
» More Mario Gabelli Articles

Commentaries and Stories

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Weekly CEO Buys Highlight: TITN, OPK, LDOS, FSFR, BRX Richard Snow,Mario Gabelli,George Soros,Joel Green - Weekly CEO Buys Highlight: TITN, OPK, LDOS, FSFR, BRX
According to GuruFocus Insider Data, these are the largest CEO buys during the past week. The overall trend of CEOs is illustrated in the chart below: More...

  • Currently 5.00/5

Rating: 5.0/5 (2 votes)

Gabelli Value 25 Fund Second Quarter Commentary Mario Gabelli - Gabelli Value 25 Fund Second Quarter Commentary
To Our Shareholders, More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Latest Real Time Picks Mario Gabelli,Dodge & Cox,Ron Baron,John Paulson - Latest Real Time Picks
The Real Time Picks section of GuruFocus is a great way to ideas from the investing gurus. We currently follow 147 guru portfolios. If a guru makes a purchase or sale of a company in which he or she owns a greater than 5 percent stake, SEC regulations require the trade to be reported within 10 days. Some of the gurus report their trades within 2 days. The type of filing can disclose whether the trade is a passive (Schedule 13G) or activist (Schedule 13D) holding. The link to the filing is available through the Real Time Picks section. The latest Real-Time Picks are from John Paulson, Ron Baron, Mario Gabelli and Dodge & Cox. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Rogers Communications: DDM Model Indicates a Long Position Joel Greenblatt,Mario Gabelli - Rogers Communications: DDM Model Indicates A Long Position
In this article, let´s consider Rogers Communications Inc. (RCI), a $20.92 billion market cap, which has a trailing P/E ratio that indicates that the stock is relatively undervalued (PE 15.5x vs Industry Median 24.9x). More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Weekly CEO Buys Highlight: OPK, BOBE, CONN, WPX, PHII Mario Gabelli,George Soros,John Rogers,David Einho - Weekly CEO Buys Highlight: OPK, BOBE, CONN, WPX, PHII
According to GuruFocus Insider Data, these are the largest CEO buys during the past week. The overall trend of CEOs is illustrated in the chart below: More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Mario Gabelli Increases Stake in 2 Companies Mario Gabelli - Mario Gabelli Increases Stake In 2 Companies
Mario Gabelli (Trades, Portfolio), founder of the $43 billion global financial services company GAMCO Investors (GBL), this week added to his positions in two stocks, Tredegar Corp (TG) and Medical Action Industries (MDCI). Gabelli’s team evaluates stocks based on fundamental bottoms-up research. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Guru Stocks at 52-Week Lows: HMC, MFG, PHG, S, HSY
According to GuruFocus list of 52-week lows, these Guru stocks have reached their 52-week lows. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Weekly 3-Year Low Highlights: GES, QLGC, NPK, PHMD, FHCO
According to GuruFocus list of 3-year lows, Guess? Inc, QLogic Corp, National Presto Industries, PhotoMedex Inc, and Female Health Co have all reached their 3-year lows. More...

WEEKLY, 3, YEAR, LOW, HIGHLIGHTS


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Top Insider Sells Highlight: Dexcom Inc.
CEO, 10% Owner of Dexcom Inc (DXCM) Terrance H Gregg sold 23,893 shares on 08/21/2014 at an average price of $44.36. The total transaction amount was $1,059,893. More...

  • Currently 3.00/5

Rating: 3.0/5 (1 vote)

DaVita Seems to be a High-Growth Company Andreas Halvorsen,Mario Gabelli - DaVita Seems To Be A High-Growth Company
In this article, let's take a look at DaVita HealthCare Partners Inc. (DVA), a $15.85 billion market cap company, which operates kidney dialysis centers and provides related lab services in outpatient dialysis centers.Main driversDaVita´s strength in dialysis should be in the future the main driver of earnings potential. When considering a number of measures, such as same-facility treatment growth and the ability to offset reimbursement pressure through internal cost controls, the company is better than competitors.The performance of the dialysis segment will remain profitable due to the increase in the aging population, rising diabetes rates and obesity epidemic. Also, international expansion is a key driver.International expansionTwo years ago, the firm acquired the company HealthCare Partners, which operates medical offices in three states. With the deal, DaVita was the largest managed health-care company in the nation. The merger offers competitive advantages over the long term, but it also adds operating risk.Earlier, the company made others acquisitions like the one of ModernMed (a Wisconsin-based clinic group) and DSI Renal Inc. that allowed the company to increase the number of clients as well as the geographies to operate.With respect to international markets, Davita has made a service agreement with Fresenius Medical Care, another leading dialysis services and products provider and made a joint venture with Riches Healthcare (RHC).The company focused on the Asia-Pacific region and for that reason acquired the dialysis operations of Malaysia's Caring Dialysis Centre Group. Other regions for expansion include Saudi Arabia, China, India and Germany.Medicare and MedicaidPatients covered by Medicare and Medicaid comprise about 90% of total treatments and about two-thirds of revenue. For each treatment, Medicare pays 80% of the amount set and the patient pays the remaining 20%. In most cases a secondary figure covers all or part of these balances. Obviously government changes to Medicare and state budget constraints on Medicaid constitute a risk for the company.Revenues, margins and profitabilityLooking at profitability, revenue growth by 10.47% but earnings per share decreased in the most recent quarter compared to the same quarter a year ago ($0.68 vs $1.19). During the past fiscal year, the firm increased its bottom line by earning $2.90 versus $2.73 in the prior year. This year, Wall Street expects an improvement in earnings ($3.63 versus $2.90).Finally, let´s compare the best measure of performance for a firm's management: the return on equity. The ROE is useful for comparing the profitability of a company to that of other firms in the same industry. Ticker Company ROE (%) DVA DaVita 14.29 AIRM Air Methods Corp. 16.94 BRLI Bio-Reference Laboratories Inc. 16.87   Industry Median 8.44 The company has a current ROE of 14.29% which is higher than the industry median. In general, analysts consider ROE ratios in the 15-20% range as representing attractive levels for investment. So for investors looking at those levels or more, Air Methods Corp. (AIRM) and Bio-Reference Laboratories Inc. (BRLI) could be the right options. It is very important to understand this metric before investing, and it is important to look at the trend in ROE over time.Relative ValuationIn terms of valuation, the stock sells at a trailing P/E of 23x, trading at a discount compared to an average of 44x for the industry. To use another metric, its price-to-book ratio of 3.2x indicates a premium versus the industry average of 2.96x while the price-to-sales ratio of 1.3x is below the industry average of 1.56x.As we can see in the next chart, the stock price has an upward trend in the five-year period. If you had invested $10,000 five years ago, today you could have $27,683, which represents a 22.6% compound annual growth rate (CAGR).Final commentAs outlined in the article, an aging population, increasing consumer awareness and new advances in technology will be the growth drivers in the next years in the healthcare industry.The company operates nearly one-third of the dialysis clinics in the U.S. and, together with Fresenius Medical Care, forms a duopoly counting nearly 70% of market share. I think the idea of expanding its dialysis operations into international markets is great although it will take time to gain significant market share.Hedge fund gurus like Mario Gabelli (Trades, Portfolio), Steven Cohen (Trades, Portfolio), Andreas Halvorsen (Trades, Portfolio) and Warren Buffet added this stock to their portfolios in the second quarter of 2014, and I would recommend that investors consider this stock for their long-term portfolios.Disclosure: Omar Venerio holds no position in any stocks mentioned More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Weekly CEO Buys Highlight: FSIC, NLY, OPK, GPC, ACXM
According to GuruFocus Insider Data, these are the largest CEO buys during the past week. The overall trend of CEOs is illustrated in the chart below: More...

  • Currently 3.00/5

Rating: 3.0/5 (2 votes)

Gabelli, Fisher and Gayner Are Betting on a Fairly Valued Stock
According to GuruFocus Guru Trades, on June 30, Mario Gabelli (Trades, Portfolio) and Ken Fisher (Trades, Portfolio) take a long position on Nike, Inc. (NKE). The company, a $67.12 billion market cap, has a trailing P/E ratio that indicates that the stock is fairly valued (25.9x vs 25.9x of industry mean). So one question arises: Why are these hedge fund managers betting on it? More...

  • Currently 3.00/5

Rating: 3.0/5 (2 votes)

PepsiCo Is a Leader in the Global Snack and Beverage Industry
In this article, let's take a look at Pepsico, Inc. (PEP), a $138.17 billion market cap company, which is a major international producer of branded beverage and snack food products. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Soros and Gabelli Top Guru Real Time Picks of the Week Mario Gabelli - Soros And Gabelli Top Guru Real Time Picks Of The Week
The following information is a highlight of the real-time guru activity we saw this week. To view more information on these gurus, check out their guru portfolios. The “Real Time Picks” reports the stock purchases and sells that Gurus have made within the prior two weeks. If a Guru makes a purchase or sell of a company in which they own a greater-than 5% stake, SEC regulations require them to report their transaction within two days. It was a quiet week in guru trades but we did see a couple of trades coming from Mario Gabelli (Trades, Portfolio) and George Soros (Trades, Portfolio). More...

  • Currently 5.00/5

Rating: 5.0/5 (2 votes)

Mario Gabelli's Top New Buys Mario Gabelli - Mario Gabelli's Top New Buys
Mario Gabelli (Trades, Portfolio)’s Gabelli Asset Fund rose 4.3% in the second quarter, compared to a 5.2% increase for the S&P 500. Gabelli wrote in his second quarter letter that he expects a continuation of M&A activity in the second half of the year and sees several factors that could affect the market going forward: More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Weekly CEO Buys Highlight: APD, OCUL, CNMD, OPK, AEGR
According to GuruFocus Insider Data, these are the largest CEO buys during the past week. The overall trend of CEOs is illustrated in the chart below: More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Mario Gabelli Comments on Xylem Inc
Xylem Inc. (XYL) (0.8%) (XYL - $39.08 - NYSE) is a global leader in the design, manufacturing, and application of highly engineered technologies for the transportation, treatment, and testing of water. The company is expected to benefit from favorable long term fundamentals in the water industry driven by scarcity, population growth, aging of the infrastructure, and the need to improve water quality. Further, with a large installed base of pumps and systems, the company is well positioned to increase aftermarket revenue, which currently represents roughly 40% of total revenues. Xylem’s attractive business mix also generates strong cash flow, which is expected to support acquisitions, debt service, and dividend growth. The company recently appointed a new CEO, Patrick Decker, who has experience in the water industry and is looking to expand geographically as well as sustainably improve operating performance. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Mario Gabelli Comments on Vivendi SA
Vivendi SA (0.4%) (VIV) (VIV - $24.47 - NYSE) is a French media and telecommunications holding company in the late stages of a decade long transition. In April 2014, the company announced it had reached an agreement to sell its French wireless operation, SFR, to French cable operator Numericable. Over the last year, the company also sold most of its 62% stake in Activision Blizzard and reached an agreement to sell its entire 53% stake in Maroc Telecom SA. After closing the SFR sale in early 2015, Vivendi will be a more focused media firm, consisting of Canal+ (a Francophone focused pay television network owner and distributor), Universal Music Group (UMG), the number one recording music company and number two music publishing entity in the world, and GVT, a fast growing Brazilian broadband and pay television provider. We expect GVT to eventually be sold and would not dismiss the possibility of a breakup of Canal+ and UMG. While operating conditions have been challenging in most of Vivendi’s businesses, it appears their trajectory is finally turning more positive and should be supported by a healthier balance sheet after More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Mario Gabelli Comments on UnitedHealth Group Inc
UnitedHealth Group Inc. (UHS) (0.2%) (UNH - $81.75 - NYSE) is the largest and most diverse health care company in the United States. United insures over forty million people around the world, but also provides over $40 billion worth of technology, pharmacy benefits management, and other care services through its Optum division. The company has successfully navigated the changes required by the Affordable Care Act and is winning new business in state Medicaid programs and in a limited number of state exchanges. UnitedHealth is also finding new growth internationally, especially in Brazil where the company now serves over four million people. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Mario Gabelli Comments on Twenty-First Century Fox Inc
Twenty-First Century Fox Inc. (FOXA) (2.2%) (FOXA - $35.15 - NASDAQ; FOX - $34.23) is a diversified media company, with operations in cable network television, television broadcasting, filmed entertainment, and direct broadcast satellite television. Cable networks account for 66% of the company’s EBITDA and benefit from contractually recurring affiliate fees and exposure to the fast-growing global pay television market. We also expect the company to benefit from rising demand for premium content, driven by emerging distribution platforms such as Netflix, retransmission revenue, and aggressive share repurchases. More...

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

Jaumepared
ReplyJaumepared - 2 months ago
I am curious how Gabelli small cap picks do in general. Anybody have any feedback?
JEANRSMITH1@GMAIL.COM
ReplyJEANRSMITH1@GMAIL.COM - 3 months ago
Kennethmall,
How is a company rated?
JEANRSMITH1@GMAIL.COM
ReplyJEANRSMITH1@GMAIL.COM - 3 months ago
What is your opinion of Markel?Is this stock overpriced?
Tomser
ReplyTomser - 9 months ago
what kind of tools he use to pick wining stcks

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK